Palmatine hydroxide
Based on 10 publication(s) in Google Scholar
Palmatine hydroxide is an orally active and irreversible indoleamine 2,3-dioxygenase 1 (IDO-1) inhibitor with IC50s of 3 μM and 157μM against HEK 293-hIDO-1 and rhIDO-1, respectively. Palmatine hydroxide can also inhibit West Nile virus (WNV) NS2B-NS3 protease in an uncompetitive manner with an IC50 of 96 μM. Palmatine hydroxide shows anti-cancer, anti-oxidation, anti-inflammatory, neuroprotection, antibacterial, anti-viral activities.
For research use only. We do not sell to patients.
- Purity: 99.64%
- CAS No.: 131-04-4
- Formula: C21H23NO5
- Molecular Weight:369.41
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
Publications Citing Use of MedChemExpress (MCE) Palmatine hydroxide
More- Phytomedicine. 2026 May 14:157:158290. [Abstract]
- Phytomedicine. 2025 Sep 4:148:157233. [Abstract]
- J Ethnopharmacol. 2024 Jan 30;319(Pt 2):117238. [Abstract]
- Int Immunopharmacol. 2022 May:106:108583. [Abstract]
- Inflammation. 2025 Dec 20;49(1):11. [Abstract]
- Biol Res. 2020 Sep 14;53(1):39. [Abstract]
- Molecules. 2024 May 14;29(10):2304. [Abstract]
- Drug Dev Res. 2022 Nov;83(7):1613-1622. [Abstract]
- Vet Microbiol. 2026 May:316:110992. [Abstract]
- Oxid Med Cell Longev. 2021 Mar 11:2021:6660193. [Abstract]
-
Bio/Physico-chemical Assay
-
In Vivo Efficacy Study
-
In Vivo Efficacy Study
-
Histological Imaging/Staining
-
Cell Imaging/Staining
All Aurora Kinase Isoforms
MoreAll Parasite Isoforms
More
Biological Activity
|
IDO-1 3 μM (IC50, HEK 293-hIDO-1) |
IDO-1 157 μM (IC50, rhIDO-1) |
WNV NS2B-NS3 96 μM (IC50) |
Palmatine (0-100 μM; 42 h) suppresses WNV with an EC50 value of 3.6 μM, and reduce the viral titers of DENV-2 and YFV with EC50 values of 26.4 μM and 7.3 μM, respectively[3].
Palmatine (0-1128 μM; 24-72 h) inhibits colon cancer cell proliferation[5].
Palmatine (0-704 μM; 24 h) reduces AURKA protein levels, induces G2/M phase arrest, and induces apoptosis in colon cancer cells via the mitochondrial associated pathway[5].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:HCT-116, SW480, HT-29
-
Concentration:0, 88, 176, 352, and 704 μM (HCT-116, SW480); 0, 141, 282, 564, and 1128 μM (HT-29)
-
Incubation Time:24, 48 and 72 h
-
Result:Decreased cell viability in a dose-dependent manner.
-
Cell Line:HCT-116, SW480, HT-29
-
Concentration:100 nM for HCT-116, 500 nM for SW480 and HT-29
-
Incubation Time:24, 48 and 72 h
-
Result:Promoted the expression of apoptosis markers such as P53 / P73, Caspase3, and Caspase9. Reduced AURKA protein levels. Increased cyt. c in the cytoplasm while reduced Bcl2 and Bcl-xl in a dose-dependent manner.
-
Cell Line:HCT-116, SW480
-
Concentration:88, 176, 352 and 704 μM
-
Incubation Time:24, 48 and 72 h
-
Result:Induced G2/M phase arrest in a dose-dependent manner.
-
Cell Line:HCT-116, SW480
-
Concentration:88, 176, 352 and 704 μM
-
Incubation Time:24, 48 and 72 h
-
Result:Induced apoptosis in a dose-dependent manner.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:DSS- induced Colitis BALB/c mice model (8-week-old)[1]
-
Dosage:50 or 100 mg/kg
-
Administration:Orally, daily, for 7 days
-
Result:Ameliorated DSS-induced colitis and prevented infiltration of inflammatory cells; remarkably extended the colon length; significantly suppressed the colonic MPO activity. Decreased the levels of colonic inflammatory cytokines (TNF-α, IFN-γ, IL-1β, IL-6, IL-4 and IL-10); Protected mucosal integrity by modulating TJs protein and apoptosis proteins; Restored DSS-induced decreases of TJ protein ZO-1, ZO-2 and claudin-1; Reduced Bax expression and enhanced Bcl-2 expression at the dose of 100 mg/kg, prevented epithelial apoptosis and improved intestinal integrity. Prevented DSS-induced changes of gut microbiota in colitis mice.
-
Animal Model:Male ICR mice (20–22 g), D-galactosamine/lipopolysaccharide (GalN/LPS)-induced fulminant hepatic failure model[2]
-
Dosage:25, 50, 100, or 200 mg/kg
-
Administration:Intraperitoneal injection, 1 h before the GalN/LPS treatment
-
Result:Attenuated the mortality and serum aminotransferase activities increased by GalN/LPS. Prevented the increase of serum TNF-α and augmented that of serum IL-10. Decreased the TNF-a mRNA expression and increased the IL-10 mRNA expression. Attenuated the apoptosis of hepatocytes.
-
Animal Model:Swiss young male albino mice, with Scopolamine (HY-N0296)- and diazepam-induced amnesia model[4]
-
Dosage:0.1, 0.5, 1 mg/kg
-
Administration:Intraperitoneal injection, 10 days
-
Result:Significantly improved learning and memory of mice at 0.5 and 1 mg/kg and did not show any significant effect on locomotor activity of the mice. Significantly reversed scopolamine- and diazepam-induced amnesia in mice. Significantly reduced brain acetylcholinesterase activity of mice.
-
Animal Model:BALB/c-nude mice, HCT-116 xenograft model[5]
-
Dosage:33.75, 67.5 and 135 mg/kg
-
Administration:Oral administration, once a day for 26 days
-
Result:The tumor volume and weight of the treatment group were significantly reduced.
Chemical Information
-
CAS No. 131-04-4
-
Appearance Solid
-
Molecular Weight 369.41
-
Formula C21H23NO5
-
Color Light yellow to yellow
-
SMILES
COC(C=C1C2=CC3=CC=C4OC)=C(C=C1CC[N+]2=CC3=C4OC)OC.[OH-]
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Publications (10)
-
Journal Impact Factor
-
Most Recent
-
Phytomedicine
Erzhi pill enhances methotrexate efficacy in rheumatoid arthritis bone homeostasis via activation of the IDO1-KYN-AhR pathway. [Abstract]2026 May 14:157:158290. PMID: 42208105 -
Phytomedicine
Huang-Lian-Jie-Du decoction enhances Capecitabine-Oxaliplatin efficacy via Akkermansia muciniphila and CD8+ T cells in colorectal cancer. [Abstract]2025 Sep 4:148:157233. PMID: 40972261 -
J Ethnopharmacol
Berberine-silybin salt achieves improved anti-nonalcoholic fatty liver disease effect through regulating lipid metabolism. [Abstract]2024 Jan 30;319(Pt 2):117238. PMID: 37774895 -
Int Immunopharmacol
Palmatine attenuates the doxorubicin-induced inflammatory response, oxidative damage and cardiomyocyte apoptosis. [Abstract]2022 May:106:108583. PMID: 35151220 -
Inflammation
Palmatine Attenuates Lipopolysaccharide-Induced Acute Lung Injury Via Suppression of NLRP3 Inflammasome Activation, Pyroptosis, and Metabolic Remodeling. [Abstract]2025 Dec 20;49(1):11. PMID: 41420798 -
Biol Res
2020 Sep 14;53(1):39. PMID: 32928312
Palmatine hydroxide purchased from MedChemExpress. Usage Cited in: Biol Res. 2020 Sep 14;53(1):39. [Abstract]
Palmatine chloride (PAL) (40 mg/kg; p.o.; once daily for 10 weeks) significantly decreased 2-h blood glucose level in HFD-fed SD rats.
Palmatine hydroxide purchased from MedChemExpress. Usage Cited in: Biol Res. 2020 Sep 14;53(1):39. [Abstract]
Palmatine chloride (PAL) (40 mg/kg; p.o.; once daily for 10 weeks) significantly decreased blood insulin levels in HFD-fed SD rats.
Palmatine hydroxide purchased from MedChemExpress. Usage Cited in: Biol Res. 2020 Sep 14;53(1):39. [Abstract]
Palmatine chloride (PAL) (40 mg/kg; p.o.; once daily for 10 weeks) restored the loss of β cell mass in HFD-fed SD rats, with predominantly increased area that stained positive for insulin.
Palmatine hydroxide purchased from MedChemExpress. Usage Cited in: Biol Res. 2020 Sep 14;53(1):39. [Abstract]
Palmatine chloride (PAL) (40 mg/kg; p.o.; once daily for 10 weeks) remarkably reduced the apoptotic rates in HFD-fed SD rats.
-
Molecules
Discovery of Nine Dipeptidyl Peptidase-4 Inhibitors from Coptis chinensis Using Virtual Screening, Bioactivity Evaluation, and Binding Studies. [Abstract]2024 May 14;29(10):2304. PMID: 38792165
Palmatine hydroxide purchased from MedChemExpress. Usage Cited in: Molecules. 2024 May 14;29(10):2304. [Abstract]
The DPP-4 inhibitory activity of Palmatine chloride (10-7-10-3 M), demeasured using dose-response curves.
-
Drug Dev Res
Palmatine attenuates hepatocyte injury by promoting autophagy via the AMPK/mTOR pathway after alcoholic liver disease. [Abstract]2022 Nov;83(7):1613-1622. PMID: 35976121 -
Vet Microbiol
The Chinese medicine monomer Schisandrin C inhibits PRRSV infection by regulating the OGT-PI3K/AKT/mTOR signaling pathway. [Abstract]2026 May:316:110992. PMID: 41865607 -
Oxid Med Cell Longev
Palmatine Protects against Cerebral Ischemia/Reperfusion Injury by Activation of the AMPK/Nrf2 Pathway. [Abstract]2021 Mar 11:2021:6660193. PMID: 33777318
Solvent & Solubility
DMSO : 15.62 mg/mL (42.28 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Purity & Documentation
-
Data Sheet (286 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Handling Instructions (2659 KB)
References
[1]. Zhang XJ, et al. Palmatine ameliorated murine colitis by suppressing tryptophan metabolism and regulating gut microbiota.Pharmacol Res. 2018 Nov;137:34-46. [Content Brief]
[2]. Lee WC, et al. Palmatine attenuates D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure in mice. Food Chem Toxicol. 2010 Jan;48(1):222-8. [Content Brief]
[3]. Jia F, et al. Identification of palmatine as an inhibitor of West Nile virus. Arch Virol. 2010 Aug;155(8):1325-9. [Content Brief]
[4]. Dhingra D, et al. Memory-enhancing activity of palmatine in mice using elevated plus maze and morris water maze. Adv Pharmacol Sci. 2012;2012:357368. [Content Brief]
[5]. Liu X, et al. Palmatine induces G2/M phase arrest and mitochondrial-associated pathway apoptosis in colon cancer cells by targeting AURKA. Biochem Pharmacol. 2020 May;175:113933. [Content Brief]
[6]. Long J, et al. Palmatine: A review of its pharmacology, toxicity and pharmacokinetics. Biochimie. 2019 Jul;162:176-184. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.7070 mL | 13.5351 mL | 27.0702 mL | 67.6755 mL |
| 5 mM | 0.5414 mL | 2.7070 mL | 5.4140 mL | 13.5351 mL | |
| 10 mM | 0.2707 mL | 1.3535 mL | 2.7070 mL | 6.7675 mL | |
| 15 mM | 0.1805 mL | 0.9023 mL | 1.8047 mL | 4.5117 mL | |
| 20 mM | 0.1354 mL | 0.6768 mL | 1.3535 mL | 3.3838 mL | |
| 25 mM | 0.1083 mL | 0.5414 mL | 1.0828 mL | 2.7070 mL | |
| 30 mM | 0.0902 mL | 0.4512 mL | 0.9023 mL | 2.2558 mL | |
| 40 mM | 0.0677 mL | 0.3384 mL | 0.6768 mL | 1.6919 mL |